Managers / Q2 2026
BALLAST ADVISORS LLC
CIK 0001803415 · 683 BIELENBERG DRIVE, SUITE 208, WOODBURY, MN, 55125-1705 · 651-478-4644
Reported Value
Under review
reported total failed a data-quality check
Positions
401
Filings on Record
28
2019–present window
Filed
Jun 23, 2026
amendment (RESTATEMENT)
Summary
Compared with Q1 2026, the fund opened 8 new positions and exited 1.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- ETP · 55.8% · $192M
- Common Stock · 36.3% · $125M
- MLP · 3.4% · $12M
- ADR · 3.0% · $10M
- Other · 1.4% · $5M
- Other · 0.1% · $343,891
Quarter-over-Quarter Changes full breakdown →
vs Q1 2026 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| MNSTMONSTER BEVERAGE CORP NEW COM | NEW | +0 | 0 | +$21 | $21 |
| KDPKEURIG DR PEPPER INC | NEW | +0 | 0 | +$12 | $12 |
| PROSHARES ULTRAPRO QQQ | NEW | +0 | 0 | +$2 | $2 |
| VSTVISTRA CORP. | NEW | +0 | 0 | +$1 | $1 |
| PURAMED BIOSCIENCE INC COM NEW | NEW | +1 | 1 | +$0 | $0 |
| GOLD HILL RES INC COM | NEW | +9 | 9 | +$0 | $0 |
| NUGENEREX IMMUNO-ONCOLOGY INC | NEW | +6 | 6 | +$0 | $0 |
| DNAGDNAPRINT GENOMICS INC COM NEW | NEW | +870 | 870 | +$0 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2026
49 positions
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q2 2026 | Under review | 401 | Jun 23, 2026 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2026 | Under review | 394 | May 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $363M | 175 | Feb 3, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $363M | 180 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $339M | 168 | Jul 31, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $314M | 164 | May 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $325M | 161 | Feb 11, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $324M | 163 | Oct 30, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $315M | 163 | Jul 26, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $297M | 172 | May 1, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $268M | 169 | Jan 30, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $251M | 178 | Oct 19, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $266M | 180 | Aug 4, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $251M | 185 | May 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $228M | 179 | Jan 26, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $214M | 177 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $222M | 182 | Jul 20, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $256M | 186 | Apr 21, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $261M | 182 | Feb 4, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $241M | 178 | Nov 1, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $236M | 179 | Jul 20, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $217M | 175 | Apr 26, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $194M | 171 | Feb 5, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $160M | 169 | Oct 22, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $141M | 160 | Jul 29, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $117M | 518 | Apr 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $136M | 163 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.